Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state.
about
MPNs as Inflammatory Diseases: The Evidence, Consequences, and PerspectivesThe Role of Reactive Oxygen Species in Myelofibrosis and Related NeoplasmsThe impact of ruxolitinib treatment on inflammation-mediated comorbidities in myelofibrosis and related neoplasmsGlycoprotein YKL-40: a novel biomarker of chronic graft-vs-host disease activity and severity?Mathematical modelling as a proof of concept for MPNs as a human inflammation model for cancer development
P2860
Circulating YKL-40 in myelofibrosis a potential novel biomarker of disease activity and the inflammatory state.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Circulating YKL-40 in myelofib ...... ty and the inflammatory state.
@en
Circulating YKL-40 in myelofib ...... ty and the inflammatory state.
@nl
type
label
Circulating YKL-40 in myelofib ...... ty and the inflammatory state.
@en
Circulating YKL-40 in myelofib ...... ty and the inflammatory state.
@nl
prefLabel
Circulating YKL-40 in myelofib ...... ty and the inflammatory state.
@en
Circulating YKL-40 in myelofib ...... ty and the inflammatory state.
@nl
P2093
P2860
P356
P1476
Circulating YKL-40 in myelofib ...... ty and the inflammatory state.
@en
P2093
Christen Lykkegaard Andersen
Mads Emil Bjørn
Morten Krogh Jensen
P2860
P304
P356
10.1111/EJH.12332
P577
2014-04-25T00:00:00Z